Baronissi, Italy

Alessandra Rosati

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Alessandra Rosati

Introduction

Alessandra Rosati is a distinguished inventor based in Baronissi, Italy. With a strong focus on medical innovations, she has made significant contributions to the field, particularly in the development of treatments for serious health conditions. Her groundbreaking work has garnered attention and respect within the scientific community.

Latest Patents

Alessandra holds a notable patent for "Humanized anti-BAG3 antibodies." This invention provides a humanized anti-BAG3 antibody or a fragment thereof, alongside pharmaceutical compositions that contain said antibody. It is particularly relevant for use as a medicament in treating pancreatic tumors, along with various immune, inflammatory, neoplastic, cardiovascular, and degenerative ailments.

Career Highlights

Throughout her career, Alessandra has demonstrated exceptional skill and dedication to advancing medical science. Her innovative approach to antibody development has positioned her as a key figure in her field, showcasing her ability to translate complex scientific concepts into practical applications that could benefit numerous patients worldwide.

Collaborations

Alessandra Rosati collaborates with talented professionals, including Maria Caterina Turco and Vincenzo De Laurenzi. Together, they contribute to Biouniversa S.r.l., where their combined expertise enhances the company's commitment to groundbreaking research and the development of innovative therapeutic solutions.

Conclusion

Alessandra Rosati’s work is a testament to the profound impact that inventors can have on health and medicine. With her expertise in developing targeted therapies, she stands at the forefront of innovation, continuously working to improve treatment options for patients facing challenging health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…